Flu Vaccine Production Down Slightly This Season; Strains Get Overhaul
Executive Summary
FDA encourages people to get vaccinations since two of the three virus strains in this season’s flu vaccines differ from last season’s; several manufacturers plan to distribute slightly fewer doses in 2012-2013 than in the prior year.
You may also be interested in...
Flu Vaccine Strain Selection Gets An Overhaul As Effectiveness “Crisis” Looms
The non-H1N1 components of this season’s influenza vaccine will be replaced for 2013-2014 as public health officials hope for a better match next season in order to improve performance.
Novartis’ Cell-based Vaccine: Seasonal Approval With Pandemic Implications
The Flucelvax flu vaccine is the first approved in the U.S. that is derived from cell-based technology instead of the traditional egg-based process. It will be made at Novartis’ Holly Springs, N.C. plant.
Flu Vaccine Demand Forecast: Flat Or Up Slightly Compared With Last Year
The five providers of the six approved seasonal influenza vaccines appear to be preparing for a similar season with similar sales in 2011-12 as they had last year.